山东大学学报(医学版) ›› 2014, Vol. 52 ›› Issue (9): 48-53.doi: 10.6040/j.issn.1671-7554.0.2014.033
黄来刚, 崔宝娟, 王晓红, 王道清, 曾凡硕, 孙敏, 刘本玲, 孙强三
HUANG Laigang, CUI Baojuan, WANG Xiaohong, WANG Daoqing, ZENG Fanshuo, SUN Min, LIU Benling, SUN Qiangsan
摘要: 目的 观察Ghrelin对兔激素性股骨头缺血性坏死(sANFH)中血管内皮生长因子(VEGF)表达的影响。方法 选择24周龄以上雄性新西兰兔34只,随机分为正常组(n=8)和造模组(n=26)。造模采用马血清联合甲基强的松龙的方法,每组各取4只行股骨头磁共振及病理组织学检查,明确造模是否成功。将造模组造模成功的20只随机分为对照组(n=10)和Ghrelin干预组(n=10),正常组剩余4只纳入空白组。Ghrelin干预组连续2周耳缘静脉注射Ghrelin[25μg/(kg·d)],对照组连续2周耳缘静脉注射相同剂量生理盐水;2周后空气栓塞法处死动物,收集标本,行股骨头组织形态学观察、RT-PCR法检测股骨头组织中VEGF的表达。结果 对照组股骨头病理组织学检查可见骨小梁广泛稀疏、大部分断裂,脂肪细胞可见融合现象;Ghrelin干预组可见骨小梁稀疏,偶见断裂;脂肪细胞较多并轻度肥大,在骨髓中所占比例多于正常组,未见融合现象。RT-PCR法检测结果显示,对照组和Ghrelin干预组VEGF表达均高于空白组(P<0.05);同时Ghrelin干预组VEGF表达明显高于对照组(P<0.05)。结论 Ghrelin可促进激素性缺血性股骨头坏死组织中VEGF mRNA的表达,从而改善坏死股骨头组织微循环,进一步改善激素性缺血性股骨头坏死的进程。
中图分类号:
| [1] 尤全喜.专家谈股骨头坏死[M]. 北京:中医古籍出版社,2003:10-12. [2] Cummings D E, Shannon M H.Roles for ghrelin in the regulation of appetite and body weight[J]. Arch Surg, 2003, 138(4):389-396. [3] Horvath, Diano S, Sotonyi P, et al. Minireview:ghrelin and the regulation of energy balance-a hypothalamic per-spective[J]. Endocrinology, 2001,142(10):4163-4169. [4] Kojima M, Hosoda H, Date Y, et al. Ghrelin is a growth-hormone-releasing acylated peptide from stomach[J]. Nature, 1999, 402(6762):656-660. [5] Date Y, Kojima M, Hosoda H, et al.Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans[J]. Endocrinology, 2000, 141(11):4255-4261. [6] Gualillo O, Caminos J E, Kojima M, et al. Gender and gonadal influences on ghrelin mRNA levels in rat stomach[J]. Eur J Endocrinol, 2001, 144(6):687-690. [7] Bowers C Y. Unnatural growth hormone-releasing peptide begets natural ghrelin[J]. J Clin Endocrinol Metab, 2001, 86(4):1464-1469. [8] Date Y, Murakami N, Kojima M,et al.Central effects of a novel acylated peptide, ghrelin, on growth hormone release in rats[J]. Biochem Biophys Res Commun, 2000, 275(2):477-480. [9] Sakata I, Nakamura K, Yamazaki M, et al. Ghrelin-producing cells exist as two types of cells, closed- and opened-type cells, in the rat gastrointestinal tract[J]. Peptides, 2002, 23(3):531-536. [10] Delhanty P J, van der Eerden B C, van Leeuwen J P.Ghrelin and bone[J]. Biofactors, 2014, 40(1):41-48. [11] Liang Q H, Liu Y, Wu S S, et al. Ghrelin inhibits the apoptosis of MC3T3-E1 cells through ERK and AKT signaling pathway [J]. Toxicol Appl Pharmacol, 2013, 272(3):591-597. [12] Fukushima N, Hanada R, Teranishi H, et al. Ghrelin directly regulates bone formation [J]. J Bone Miner Res, 2005, 20(5):790-798. [13] Maccarinelli G, Sibilia V, Torsello A, et al. Ghrelin regulates proliferation and differentiationof osteoblastic cells[J]. J Endocrinol, 2005, 184(1):249-256. [14] Fukushima N, Hanada R, Teranishi H, et al. Ghrelin directly regulates bone formation[J]. J Bone Miner Res, 2005, 20(5):790-798. [15] Maccarinelli G, Sibilia V, Torsello A,et al.Ghrelin reg-ulates proliferation and differentiation of osteoblastic cells [J]. J Endocrinol, 2005, 184(1):249-256. [16] Larsson B, Norlén P, Lindström E, et al. Effects of ECL cell extracts and granule/vesicle-enriched fractions from rat oxyntic mucosa on cAMP and IP(3) in rat osteoblast-like cells[J]. Regul Pept, 2002, 106(1-3):13-18. [17] Kerachian M A, Harvey E J, Cournoyer D, et al. Avascular necrosis of the femoral head: vascular hypotheses [J]. Endothelium, 2006, 13(4):237-244. [18] Feng L, Wu H, E L, et al.Effects of vascular endothelial growth factor 165 on bone tissue engineering [J]. PLoS ONE, 2013, 8(12):82945. [19] Turner N, Grose R. Fibroblast growth factor signalling:from development to cancer [J]. Nat Rev Cancer, 2010, 10(2):116-129. [20] Horner A, Bishop N J, Bord S, et al. Immunolocalisation of vascular endothelial growth factor (VEGF) in human neonatal growth plate cartilage[J]. J Anat, 1999, 194(4):519-524. [21] Petersen W, Pufe T, Zantop T, et al. Expression of VEGFR-1 and VEGFR-2 in degenerative Achilles tendons [J]. Jorthop Res, 2004(420):286-291. [22] Pufe T, Claassen H, Scholz-Ahrens K E, et al. Influence of estradiol on vascular endothelial growth factor expression in bone: a study in Göttingen miniature pigs and human osteoblasts [J]. Calcif Tissue Int, 2007, 80(3):184-191. [23] Vadasz Z, Misselevich I, Normman D, et al. Localization of vascular endothelial growth factor during the early reparative phase of the rats' vessels deprivation-induced osteonecrosis of the femoral heads [J]. Exp Mol Pathol, 2004, 77(2):145-148. |
| [1] | 王韶卿 刘毅慧 付婷婷 成金勇 刘强. 肝癌31磷磁共振波谱数据的分类[J]. 山东大学学报(医学版), 2209, 47(6): 42-46. |
| [2] | 黄方 康瑞 吴春林. VEGFC、NF-κBp65及Survivin在鼻咽癌中的表达及临床意义[J]. 山东大学学报(医学版), 2209, 47(6): 83-. |
| [3] | 金晨曦,沈薇,李娜,孙建锋,杨驰,郭泾. ADDWoR关节镜下盘复位术盘-髁运动的定量分析[J]. 山东大学学报 (医学版), 2025, 63(7): 54-61. |
| [4] | 王磊,常霄,王梓萌,李娇娇,崔书君,杨飞,朱月香. 瘤内及瘤周DCE-MRI影像组学对宫颈癌患者无进展生存期的预测价值[J]. 山东大学学报 (医学版), 2025, 63(6): 45-54. |
| [5] | 单体晓,杜韦辰,王勤周,李安宁,李春海. 自身免疫性郎飞结病磁共振成像研究进展[J]. 山东大学学报 (医学版), 2025, 63(11): 117-122. |
| [6] | 刘晶晶,庞婧,赵晓丹,林昕,付敏,陈静静. 基于乳腺X线摄影及DCE-MRI机器学习模型预测乳腺癌新辅助治疗后病理完全缓解:双中心研究[J]. 山东大学学报 (医学版), 2025, 63(1): 60-72. |
| [7] | 姜俊,高洪莲,孙瑞婷,孙昕,彭庆生,张守宽,张磊. 血管内皮生长因子-B对形觉剥夺性近视豚鼠视网膜中多巴胺水平的影响[J]. 山东大学学报 (医学版), 2024, 62(7): 62-71. |
| [8] | 刘小文,曹永泉,侯明源,于德新. EOB-MRI多定量参数对肝胆期乏血供低信号结节进展风险的评估价值[J]. 山东大学学报 (医学版), 2024, 62(4): 31-39. |
| [9] | 吴思雨,沈业隆,王锡明. 影像组学预测原发性中枢神经系统淋巴瘤的Ki-67标记指数[J]. 山东大学学报 (医学版), 2024, 62(11): 67-72. |
| [10] | 靳新娟,左立平,邓展昊,李安宁,于德新. MRI影像组学对135例肝癌耐药蛋白PFKFB3的预测价值[J]. 山东大学学报 (医学版), 2023, 61(6): 79-86. |
| [11] | 李晴,张安娜,杜艳圣,刁久洲,崔若瑾,付鹏蕊,岳欣毅,周庆博. 47例单个脊髓炎性脱髓鞘病灶转化的影响因素[J]. 山东大学学报 (医学版), 2023, 61(5): 37-43. |
| [12] | 王磊,张帅,刘钢,由胜男,王植,朱珊,陈超,马信龙,杨强. MRI诊断140例腰椎智能网络自动检测分型MCs方法的比较[J]. 山东大学学报 (医学版), 2023, 61(3): 71-79. |
| [13] | 杨咏青,赵鹏,汪玉,马文静,田迷迷,程亚旎,祖璐,林祥涛. 细胞外容积分数对62例不同病理类型肺癌的诊断价值[J]. 山东大学学报 (医学版), 2023, 61(2): 88-94. |
| [14] | 靳新娟,蔡大幸,范金蕾,邓展昊,李楠,于德新,李安宁. 显微镜高分辨率MRI鉴别皮肤良、恶性局灶隆起性结节[J]. 山东大学学报 (医学版), 2023, 61(12): 51-61. |
| [15] | 赵恩举,赵硕,郭云亮,王锡明. 282例颈动脉钙化与脑小血管病MRI总负荷评分的关联性[J]. 山东大学学报 (医学版), 2023, 61(1): 38-44. |
|
||